ABSTRACT: Purpose. This study compares retinoscopy in infants using a near noncycloplegic technique, cycloplegia with tropicamide 1%, and cycloplegia with cyclopentolate 1%. The study sample included 29 healthy, nonstrabismic infants 4 to 7 months of age (mean 5.71 months). Methods. Each study subject was examined at two separate visits an average of 2 weeks apart (mean [؎SD] 14 ؎ 9 days). The examiner completed a case history, iris color grading, confrontation tests, and noncycloplegic near retinoscopy in a dark room and then instilled a drop of topical anesthetic in each eye followed by 2 drops of cycloplegic agent separated by 5 min. Retinoscopy was performed 25 to 30 min after the first drops were instilled. The bottles were masked, and the drop administered at the first visit was randomly assigned. Results. On a scale of 0 to 4.9, the median iris grade was 4.0, which corresponds to a brown or darkly pigmented iris. 
D
uring the routine examination of nonstrabismic infants, the eye care practitioner must decide whether or not to use a cycloplegic agent. A useful noncycloplegic method is described by Mohindra. 1, 2 This procedure is completed at 50 cm in a dark room. The intensity of the light is maintained at a minimum, and the child is encouraged to fixate the light with one eye while the other is occluded by the parent. The method is based on the observation that when viewing a retinoscope light monocularly at 50 cm in a darkened room, the accommodative response of adult subjects remains stable at 0.70 D. 3 The American Optometric Association recommends the near noncycloplegic technique when frequent follow-up is necessary, when the child is extremely anxious about instillation of cycloplegic agents, and when the child has had or is at risk for an adverse reaction to cyclopentolate or tropicamide. 4 Saunders and Westall 5 completed a repeatability study on 74 infants and children, comparing the Mohindra technique with retinoscopy after the instillation of cyclopentolate. Noncycloplegic retinoscopy revealed on average 0.39 D less hyperopia than cycloplegic retinoscopy. The authors concluded that noncycloplegic retinoscopy could be substituted for cycloplegic retinoscopy but qualified their recommendation by stating "when a poor confidence near retinoscopy result is obtained, a cycloplegic refraction is advised." Borghi and Rouse 6 also found a good correlation be-tween the near noncycloplegic retinoscopy technique and cycloplegic retinoscopy with cyclopentolate. Cycloplegic retinoscopy with cyclopentolate found on average 0.50 to 0.75 D more hyperopia than noncycloplegic retinoscopy. Wesson et al., 7 on the other hand, recommended that caution be used when substituting near noncycloplegic retinoscopy for cycloplegic refraction. In their infant group, they found on average 2.12 D more hyperopia using cycloplegic retinoscopy with cyclopentolate compared with the near noncycloplegic technique.
To reliably assess refractive error, many clinicians choose to inhibit accommodation with a cycloplegic agent. Cyclopentolate is a widely used cycloplegic agent with rapid onset and relatively short duration. It is commercially available in strengths of 0.5% and 1.0%. The 1% concentration is often recommended for infants and children Ͻ12 years of age. 8 Some practitioners recommend the 0.5% concentration for neonates and infants, 9, 4 presumably to decrease the chances of systemic side effects. We selected the 1% concentration for our study because it is considered to be the gold standard by which other cycloplegic agents are compared.
Cyclopentolate provides a depth of cycloplegia that is sufficient for the majority of cases because it limits residual accommodation to between 1.00 and 2.50 D. 10 -15 Priestly and Medine 16 found that residual accommodation ranged between 0.50 and 1.75 D, with an average of 1.25 D. The time course is acceptable for clinical practice, with maximal cycloplegia occurring within 30 to 60 min of instillation of the first drop. O'Connor-Davies et al. 8 found that the average time to maximum cycloplegia was 34 min, with a range of 10 to 55 min.
The amount of iris pigmentation has been reported to affect the time course of cycloplegic agents. Manny et al. 17 found that for individuals with dark irises, 30 to 40 min is required for maximal cycloplegia with 1 drop of cyclopentolate 1%. The magnitude of residual accommodation for individuals with dark irises was similar to that found in individuals with light irises at 10 min. Lovasik 18 reported that the rate of accommodative loss was slower in adults with dark irises compared with light irises. The rate of accommodative loss for cyclopentolate 1% after instillation of proparacaine was 1.80 Ϯ 0.24 D/min for blue irises compared with 1.38 Ϯ 0.18 D/min for brown irises.
Some clinicians, however, avoid the use of cyclopentolate for routine eye examination in infants because of the concern for potential systemic side effects. Over the years, numerous case reports have been published which associate the drug with central nervous system side effects such as cerebellar dysfunction, visual and tactile hallucinations, drowsiness, ataxia, seizures, facial flushing, and tachycardia. 19 -22 Many of these adverse reactions occurred with cyclopentolate 2%, whereas most practitioners today use cyclopentolate 1%. Nevertheless, because of these reports, some eye care practitioners reserve cyclopentolate for the examination of infants and children with strabismus or other ocular anomalies.
Tropicamide is another widely used cycloplegic agent. It is commercially available in concentrations of 0.5% and 1.0%. For the purposes of cycloplegia, the 1% concentration is recommended over the 0.5%. 8 Using 2 drops of tropicamide 1%, residual accommodation is usually Ͻ2.00 D and the interval of maximal cycloplegia is 20 to 35 min. 12 The duration of cycloplegia is short-lived, however, and quickly recovers after 35 min accommodation.
Mishima 23 and Maurice and Mishima 24 estimated that tropicamide is eliminated from the receptor sites about three times more quickly than cyclopentolate, thereby significantly reducing its bioavailability for inducing cycloplegia. The amount of iris pigmentation affects tropicamide as well. The rate of accommodative loss for tropicamide 1% after instillation of proparacaine was 1.26 Ϯ 0.12 D/min for blue irises compared with 0.72 Ϯ 0.24 D/min for brown irises. Tropicamide is a safe diagnostic pharmaceutical agent. In a review of 15,000 diagnostic pharmaceutical applications, Yolton et al. 25 reported no adverse systemic effects for tropicamide.
The main drawback of tropicamide is that some studies have demonstrated a lack of deep cycloplegic effect. Milder 13 found that six cases in his series up to 9 years of age had an average of 6.25 D of residual accommodation after 30 min. In 20 cases from ages 10 to 14 years, residual accommodation was an average of 3.65 D. Lovasik 18 estimates that 1 drop of tropicamide 0.5% or 1.0% might leave 28% to 40% of the normal accommodative amplitude intact. He concludes that this amount of residual accommodation is unsatisfactory for most refractive purposes. Hiatt and Jerkins 26 found that tropicamide was less effective as a cycloplegic for preschool children with esotropia.
The studies of residual accommodation are important and can be a helpful guide to the usefulness of a cycloplegic agent. Nevertheless, the practitioner is generally most interested in a reliable measure of refractive error. Despite its poorer performance as a cycloplegic agent compared with cyclopentolate in terms of inhibiting accommodation, tropicamide has been found to provide adequate cycloplegia for measurement of refractive error. Egashira et al. 27 reported that in hyperopic 6 to 12-year-old children, there was no statistically significant difference between cyclopentolate and tropicamide for either cycloplegic retinoscopy or subjective refraction. There was, however, a statistically significant but clinically unimportant bias of 0.14 D toward more hyperopia with cyclopentolate when autorefraction was used.
We wanted to evaluate whether tropicamide might be a useful cycloplegic agent for the routine examination of nonstrabismic infants, taking advantage of its wider margin of safety and faster recovery time compared with cyclopentolate, as well as its potential for revealing more hyperopia than noncycloplegic retinoscopy.
METHODS
Twenty-nine subjects, 18 girls and 11 boys, aged 4 to 7 months participated in the study (mean age [ϮSD] 5.7 Ϯ 0.7 months) after appropriate informed consent procedures administered to the parents in a language in which they were fluent. The study was performed at La Clinica de la Raza in Oakland, California, and all of the participants were Hispanic, which corresponds to the patient base of the Clinic. The protocol and informed consent forms were reviewed and approved by the University of California, Berkeley Committee for the Protection of Human Subjects. Each study subject was examined at two separate visits an average of 2 weeks apart (mean 14 Ϯ 9 days). All subjects had normal ocular health with no strabismus.
All of the examination procedures in this study were completed by one examiner (JDT). He completed a case history and confrontation tests including Hirschberg angles, near point of conver-216 Cycloplegic Retinoscopy in Infants-Twelker & Mutti gence, pupil response testing, and extraocular muscle motility. The examiner graded iris color using a slight modification of the method described by Seddon et al. 28 and recorded a grade of 0 to 4.9 with decimalization to the nearest 0.1 units. The four standard plates were assigned grades 1 through 4, where standard A was the least pigmented (grade 1) and standard D the most heavily pigmented (grade 4).
During all retinoscopy procedures, individual trial lenses rather than lens bars were used to neutralize the reflex. The examiner first completed noncycloplegic near retinoscopy in a dark room as described by Mohindra.
2 Rather than the 1.25 D correction recommended by Mohindra, we subtracted 0.75 D from the near retinoscopy result as recommended by Saunders and Westall. 5 The Saunders and Westall study used a larger sample size than the Mohindra study, and more important, the conclusions were based on a sample of infant subjects rather than adult subjects.
The examiner inadvertently used a nonstandard technique for the first five study subjects. Instead of covering the nontested eye, the examiner performed retinoscopy while the infant was binocular. The first study subject received binocular testing at both visits. Subjects 2 through 5 received binocular testing on the first visit only and the proper monocular technique at the second visit. Subjects 6 through 29 received the monocular technique at both visits.
After noncycloplegic retinoscopy, the examiner instilled a drop of proparacaine hydrochloride 0.5% (AK-Taine, Akorn, Buffalo Grove, IL) in each eye followed by 2 drops of tropicamide 1% or cyclopentolate 1%, separated by 5 min (Tropicacyl, Akorn, Buffalo Grove, IL or AK-Pentolate, Akorn, Abita Springs, LA). The examiner then waited another 20 min. In all cases, the subject and parent were called into the examination room 25 min after the initial eye drop. Depending on how long it took the subject and parent to settle into the examination chair, retinoscopy was performed 25 to 30 min after the initial eye drop. The same time course was used for both cycloplegic agents. After retinoscopy, the examiner completed a dilated fundus examination.
The bottles containing both cycloplegic agents were masked, and the drop that was administered at the first visit was randomly assigned. At the second visit, the examiner was masked to all prior noncycloplegic and cycloplegic retinoscopy findings. Some workers have noticed that there is a difference in odor between tropicamide 1% and cyclopentolate 1%. The examiner was unaware of this difference at the time of the examinations and was not unmasked by any difference in odor at the arm's length distance used for drop instillation during testing.
RESULTS

Iris Grading
The median iris grade for visit 1 was 4.0 (range 1.4 to 4.9) and for visit 2 was 4.1 (range 0.8 to 4.8), which corresponds to a brown or darkly pigmented iris. There was no statistically significant difference between grades for visits 1 and 2 (t ϭ Ϫ1.00, p ϭ 0.33, two-sided paired t-test). Fig. 1 shows the difference between visits on the y axis vs. the mean of iris grade on the x axis. The solid line represents the mean difference between visits of Ϫ0.1 units (Ϯ0.3). The gray shaded area represents the 95% limits of agreement of Ϯ0.61 units between visits. As seen in Fig. 1 , nearly all subjects had a brown or dark brown iris. Iris color was not analyzed further due to this limited variation.
Noncycloplegic Retinoscopy
For the purposes of assessing repeatability of the spherical component of refractive error, the reported results are for the horizontal meridian of the right eye. Study subjects 1 through 5 were excluded from the analysis of noncycloplegic results because of nonstandard technique as described in the methods section.
The mean noncycloplegic retinoscopy was ϩ0.84 D (Ϯ1.22 D) for visit 1 and ϩ1.04 D (Ϯ1.31 D) for visit 2. The mean difference between visits was Ϫ0.20 D (Ϯ0.86 D). Fig. 2 shows the difference between visits on the y axis vs. the mean of noncycloplegic retinoscopy on the x axis. The solid line represents the mean difference between visits of Ϫ0.20 D. The gray shaded area represents the 95% limits of agreement of Ϯ1.78 D between visits. We performed a linear regression to determine whether there was a range effect between the difference (visit 1 minus visit 2) and mean refractive error. The analysis suggests that there is no relationship between retinoscopic difference and mean refractive error (y ϭ Ϫ0.08x ϩ 0.12, R 2 ϭ 0.01, p ϭ 0.60). The mean of both noncycloplegic visits was ϩ0.94 D (Ϯ1.19 D). D) . There was no statistically or clinically significant difference between the two measurements using different cycloplegic agents (t ϭ Ϫ0.46, p ϭ 0.65, two-sided paired t-test). Fig. 3 shows the difference between the two cycloplegic agents on the y axis vs. the mean of both on the x axis. The solid line represents the mean difference between visits of 0.07 D. The gray shaded area represents the 95% limits of agreement of Ϯ1.65 D between visits. There were no serious adverse reactions with either agent, although one infant temporarily developed redder than normal cheeks after instillation of cyclopentolate.
Cycloplegic Retinoscopy
We performed a linear regression on the relative difference between cycloplegic measurements (cyclopentolate minus tropicamide) and the mean refractive error as shown in Fig. 3 . The purpose was to investigate any linear relationship that might be present between the two variables. The results suggest that the retinoscopic difference between agents increases with increasing mean refractive error, although it is not significant at the 95% level (y ϭ 0.22x Ϫ 0.33, R 2 ϭ 0.12, p ϭ 0.07).
Difference between Noncycloplegic and Cycloplegic Retinoscopy Table 1 shows that the mean difference between noncycloplegic and cycloplegic retinoscopy was 0.89 D (Ϯ0.66 D; t ϭ Ϫ6.57, p Ͻ 0.0001) with tropicamide and 1.04 D (Ϯ0.94 D; t ϭ Ϫ5.38, p Ͻ 0.0001; all two-sided paired t-tests) with cyclopentolate. Fig. 4a shows the difference between the tropicamide and noncycloplegic retinoscopy on the y axis vs. the mean of both on the x axis. The solid line represents the mean difference between measurements of 0.89 D. The gray shaded area represents the 95% limits of agreement of Ϯ1.37 D between visits. Fig. 4b shows the difference between the cyclopentolate and noncycloplegic retinos-
The gray shaded area represents the 95% limits of agreement of Ϯ1.95 D between visits.
We performed a linear regression to determine whether there was a range effect between the difference (cycloplegic minus noncycloplegic) and mean refractive error. The analysis suggests that there is no relationship between the difference and mean refractive error for tropicamide or cyclopentolate (tropicamide, y ϭ 0.03x ϩ 0.84, R 2 Ͻ 0.01, p ϭ 0.78; cyclopentolate, y ϭ 0.17x ϩ 0.79, R 2 Ͻ 0.01, p ϭ 0.31). 
Astigmatism
DISCUSSION
Tropicamide 1% and cyclopentolate 1% resulted in similar retinoscopy results for most infant subjects. The mean difference was 0.07 D (Ϯ0.80 D, t ϭ Ϫ0.46, p ϭ 0.65, two-sided paired t-test) for the horizontal meridian of the right eye. This result suggests that tropicamide is as effective when measuring refractive error as cyclopentolate in a nonstrabismic infant population. The dark iris color of the sample makes this a particularly interesting comparison because both cyclopentolate and tropicamide have been reported to be less effective in persons with dark irises compared with light irises.
It might be argued that our subject sample was even more hyperopic than was measured with cyclopentolate. Maximum cycloplegia ranges between 20 to 30 min for tropicamide 12 and 30 to 40 min for cyclopentolate. 17 We performed retinoscopy 25 to 30 min after the first drop was instilled. Therefore, for tropicamide cycloplegia, the examiner performed retinoscopy in the range of maximum cycloplegia. This should not bias our results substantially, however; the differences reported by Manny et al. 17 in optometermeasured residual accommodation 20 and 30 min after cyclopentolate 1% in subjects with dark irises were small (about 0.25 D).
When cycloplegia is incomplete, the examiner sometimes notes that the subject is accommodating during retinoscopy. This is seen as a fluctuation in the retinoscopy reflex and/or the refractive error measurement. Although there was no formal evaluation of this in the testing protocol, the examiner did not note any cases of incom- 218 Cycloplegic Retinoscopy in Infants-Twelker & Mutti plete cycloplegia during the infant examinations. Another potential sign of incomplete cycloplegia is an increased astigmatism measurement. As the examiner moves from the horizontal meridian to the vertical meridian, a patient for whom cycloplegia is not complete might accommodate, resulting in increased astigmatic measures. Table 2 shows that the difference between tropicamide and cyclopentolate astigmatic refractive error for the right eye was not significant with an average difference of Ϫ0.01 D (Ϯ0.92 D; t ϭ 0.05, p ϭ 0.96, two-sided paired t-test).
Both agents clearly had a cycloplegic effect. Both tropicamide and cyclopentolate uncovered more hyperopia than noncycloplegic retinoscopy (0.89 Ϯ 0.66 D, t ϭ Ϫ6.57, p Ͻ 0.0001 and 1.04 Ϯ 0.94 D, t ϭ Ϫ5.38, p Ͻ 0.0001, respectively). Furthermore, cycloplegic retinoscopy using tropicamide (and cyclopentolate) was much easier to perform compared with noncycloplegic retinoscopy. The pupils were larger, which made the motion of the reflex much easier to interpret. More important, the infant subjects sat much more quietly and maintained fixation much better than when we used the noncycloplegic technique as described by Mohindra. 2 When the parent gently covered the eye not being tested, most infants tried to avoid the cover and often became agitated or began to cry. This made retinoscopy more difficult to perform. Under binocular conditions, on the other hand, most infants were relatively cooperative during retinoscopy.
The process of instilling eye drops also causes some temporary agitation and crying in most infants. But, unlike the near Mohindra technique, the agitation occurs 25 min earlier than the retinoscopy procedure, not simultaneously. Most infants recover very quickly from any agitation induced by instilling eye drops.
We found that the linear relationship between the difference between cycloplegic measurements (cyclopentolate minus tropicamide) and the mean refractive error was not statistically significant (y ϭ 0.22x Ϫ 0.33, R 2 ϭ 0.12, p ϭ 0.07). Because of the positive sign on the slope, a type II error here suggests that retinos- copy using tropicamide cycloplegia might underestimate refractive error in cases of moderate to high hyperopia. Closer examination of Fig. 3 indicates that this is not the case. The trend toward a positive slope appears to be influenced by two points that indicate a more hyperopic result with tropicamide, not cyclopentolate, at near emmetropic mean refractive errors. When refractive error is more hyperopic than ϩ2.00 D, the two cycloplegic agents give results that are within Ϯ1.00 D of each other with no evidence of underestimation of hyperopia with tropicamide. Although this study is not intended to be a cross-sectional study of refractive error in 6-month-old infants, it is interesting to note that both tropicamide and cyclopentolate measures of refractive error (ϩ1.81 Ϯ 1.19 D and ϩ1.88 Ϯ 1.45 D, respectively) are similar to those found in large studies of refractive error in infants. More hyperopia was found by Ehrlich and co-workers 29 (an average mean for the right eye most positive meridian of ϩ2.50 Ϯ 1.40 D in 254 infants) and slightly less hyperopia by Frane and coworkers 30 (an average of ϩ1.31 Ϯ 1.10 D in 216 infants) in two separate studies of 9-month-old infants using cyclopentolate cycloplegic retinoscopy. Our results might be applicable to a broad range of subjects of various ethnicities and iris colors.
When interpreting the results of any research investigation, one must consider the potential for bias due to measurement error. This project was completed entirely by one examiner, therefore there was no interobserver bias. We can assess intraobserver repeatability for noncycloplegic retinoscopy because the same procedure was completed at both examination visits. The 95% limits of agreement were Ϯ1.78 D. In this study, it is not possible to directly assess intraobserver repeatability for cycloplegic retinoscopy because a different cycloplegic agent was used at each study visit. If you make the assumption that there was little to no variability due to using a different cycloplegic agent from visit to visit, which this study supports, then the 95% limits of agreement would be Ϯ1.65 D. In a study comparing retinoscopy in a sample of 20 hyperopic 6-to 12-year-old children, 27 the 95% limits of agreement were Ϯ0.63 D. This implies that retinoscopy is more difficult to perform in infants compared with school-age children, which is not unexpected. A second consideration when no significant differences are found between two techniques is the adequacy of the sample size, or the power of the study to find a difference if one exists. The study power is Ͼ90% to detect a difference of 0.50 D between cycloplegic agents at a sample size of 29 and standard deviation of differences of Ϯ0.80 D.
Most infants tend to hold a steady gaze for only short periods of time. Therefore, the examiner must be quick in obtaining an end point, while also trying to maximize accuracy. Even though fixa- 220 Cycloplegic Retinoscopy in Infants-Twelker & Mutti tion aids can help the infant maintain a steady gaze, the examiner must be able to identify when he or she is off-axis with respect to the line of sight, which can bias results. The infant often tries to grab the individual trial lens that is used for neutralizing the retinoscopic reflex, and the lens bar can be even more difficult because it presents and even larger target. Some infants, for any number of reasons, simply do not want to sit still or open their eyes. And, of course, some will cry.
Retinoscopy in infants is inherently imprecise, which can lead to an inaccurate result. Given only one estimate, it is impossible for the practitioner to know whether the result is inaccurate. It is important to think of one estimate, not as the infant's refractive error, but rather as one piece of evidence leading to knowing the infant's refractive error. Repeated retinoscopy, either during the same session a few minutes later or on another day, can lead to increased confidence in the result. Conversely, it can lead to doubt in the initial retinoscopy result, which is equally important information.
Noncycloplegic retinoscopy as described by Mohindra, 2 although it is simply a modification of standard retinoscopy, takes time and practice to perform reliably. The authors recommend practical experience with about 8 to 10 infant patients before the clinician is comfortable with the procedure. This is a significant drawback for the primary care optometrist who only infrequently examines an infant patient. Cycloplegic retinoscopy, on the other hand, is a procedure that is much more commonly performed in most clinics. Although it is true that performing the procedure on a less than cooperative infant can be difficult, the procedure is still a familiar one. For the clinician who completes a limited number of infant examinations per year, we recommend cycloplegic retinoscopy. Specifically, we recommend retinoscopy using tropicamide because it appears to be effective as cyclopentolate. Its wider mar- gin of safety and faster recovery time are important practical considerations.
CONCLUSIONS
The American Optometric Association recommends a complete eye examination at about 6 months of age. This recommendation could result in the detection of visual abnormalities at an early age, often when they are more amenable to treatment to prevent amblyopia. Good examples of conditions amenable to early treatment to prevent amblyopia are strabismus, astigmatism, high hyperopia, and anisometropia. Nevertheless, the examination of infants presents some important challenges. Certainly, near noncycloplegic retinoscopy as described by Mohindra is an important technique that optometrists have at their disposal, but it has been reported to be unreliable. Cycloplegic retinoscopy using cyclopentolate is the gold standard by which other methods are compared. However, some practitioners hesitate to use cyclopentolate unless it is necessary because of reports of rare adverse reactions. This study presents tropicamide as a viable option for inducing cycloplegia in infants. Tropicamide appears to be as effective as cyclopentolate for the measurement of refractive error in most nonstrabismic infants.
